Cargando…

Identifying absorbable bioactive constituents of Yupingfeng Powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis

OBJECTIVE: Yupingfeng Powder (YPF), a kind of preventative patent medicine, is chosen for treatment of coronavirus disease 2019 (COVID-19) due to its high frequency application in respiratory tract diseases, such as chronic obstructive pulmonary disease, asthma, respiratory tract infections, and pne...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Linyan, Du, Zhongyan, Guan, Yang, Wang, Bo, Pei, Yanling, Zhang, Lizong, Fang, Mingsun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828289/
https://www.ncbi.nlm.nih.gov/pubmed/35165529
http://dx.doi.org/10.1016/j.chmed.2022.02.001
_version_ 1784647814102384640
author Wang, Linyan
Du, Zhongyan
Guan, Yang
Wang, Bo
Pei, Yanling
Zhang, Lizong
Fang, Mingsun
author_facet Wang, Linyan
Du, Zhongyan
Guan, Yang
Wang, Bo
Pei, Yanling
Zhang, Lizong
Fang, Mingsun
author_sort Wang, Linyan
collection PubMed
description OBJECTIVE: Yupingfeng Powder (YPF), a kind of preventative patent medicine, is chosen for treatment of coronavirus disease 2019 (COVID-19) due to its high frequency application in respiratory tract diseases, such as chronic obstructive pulmonary disease, asthma, respiratory tract infections, and pneumonia, with the advantage of reducing the relapse rate and the severity. However, the active components of YPF and the mechanisms of components affecting COVID-19 are unclear. This study aimed to determine active constituents and elucidate its potential mechanisms. METHODS: Ultra performance liquid chromatography-quadrupole-time of flight mass spectrometry (UPLC-Q/TOF-MS) and liquid chromatography-triple quadrupole mass spectrometry (LC-QQQ-MS) were used to determine the components and absorbable constituents of YPF. Secondly, TCMSP, Drugbank, Swiss and PharmMapper were used to search the targets of absorbable bioactive constituents of YPF, and the targets of COVID-19 were identified based on GeneCards and OMIM databases. STRING database was used to filter the possible inter-protein interactions. Thirdly, Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analysis were performed to identify molecular function and systemic involvement of target genes. RESULTS: A total of 61 components of YPF and 36 absorbable constituents were identified through UPLC-Q/TOF-MS. Wogonin, prim-O-glucosylcimifugin, 5-O-methylvisamminol, astragaloside IV and 5-O-methylvisamminol (hydroxylation) were vital constituents for the treatment of COVID-19, and RELA, TNF, IL-6, MAPK14 and MAPK8ere recognized as key targets of YPF. The major metabolic reactions of the absorbed constituents of YPF were demethylation, hydroxylation, sulfation and glucuronidation. GO and KEGG pathway analysis further showed that the most important functions of YPF were T cell activation, response to molecule of bacterial origin, cytokine receptor binding, receptor ligand activity, cytokine activity, IL-17 signaling pathway, Chagas disease, lipid and atherosclerosis, etc. CONCLUSION: The approach of combining UPLC-Q/TOF-MS with network pharmacology is an effective tool to identify potentially bioactive constituents of YPF and its key targets on treatment of COVID-19.
format Online
Article
Text
id pubmed-8828289
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88282892022-02-10 Identifying absorbable bioactive constituents of Yupingfeng Powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis Wang, Linyan Du, Zhongyan Guan, Yang Wang, Bo Pei, Yanling Zhang, Lizong Fang, Mingsun Chin Herb Med Original Article OBJECTIVE: Yupingfeng Powder (YPF), a kind of preventative patent medicine, is chosen for treatment of coronavirus disease 2019 (COVID-19) due to its high frequency application in respiratory tract diseases, such as chronic obstructive pulmonary disease, asthma, respiratory tract infections, and pneumonia, with the advantage of reducing the relapse rate and the severity. However, the active components of YPF and the mechanisms of components affecting COVID-19 are unclear. This study aimed to determine active constituents and elucidate its potential mechanisms. METHODS: Ultra performance liquid chromatography-quadrupole-time of flight mass spectrometry (UPLC-Q/TOF-MS) and liquid chromatography-triple quadrupole mass spectrometry (LC-QQQ-MS) were used to determine the components and absorbable constituents of YPF. Secondly, TCMSP, Drugbank, Swiss and PharmMapper were used to search the targets of absorbable bioactive constituents of YPF, and the targets of COVID-19 were identified based on GeneCards and OMIM databases. STRING database was used to filter the possible inter-protein interactions. Thirdly, Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analysis were performed to identify molecular function and systemic involvement of target genes. RESULTS: A total of 61 components of YPF and 36 absorbable constituents were identified through UPLC-Q/TOF-MS. Wogonin, prim-O-glucosylcimifugin, 5-O-methylvisamminol, astragaloside IV and 5-O-methylvisamminol (hydroxylation) were vital constituents for the treatment of COVID-19, and RELA, TNF, IL-6, MAPK14 and MAPK8ere recognized as key targets of YPF. The major metabolic reactions of the absorbed constituents of YPF were demethylation, hydroxylation, sulfation and glucuronidation. GO and KEGG pathway analysis further showed that the most important functions of YPF were T cell activation, response to molecule of bacterial origin, cytokine receptor binding, receptor ligand activity, cytokine activity, IL-17 signaling pathway, Chagas disease, lipid and atherosclerosis, etc. CONCLUSION: The approach of combining UPLC-Q/TOF-MS with network pharmacology is an effective tool to identify potentially bioactive constituents of YPF and its key targets on treatment of COVID-19. Elsevier 2022-02-09 /pmc/articles/PMC8828289/ /pubmed/35165529 http://dx.doi.org/10.1016/j.chmed.2022.02.001 Text en © 2022 Tianjin Press of Chinese Herbal Medicines. Published by ELSEVIER B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Wang, Linyan
Du, Zhongyan
Guan, Yang
Wang, Bo
Pei, Yanling
Zhang, Lizong
Fang, Mingsun
Identifying absorbable bioactive constituents of Yupingfeng Powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis
title Identifying absorbable bioactive constituents of Yupingfeng Powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis
title_full Identifying absorbable bioactive constituents of Yupingfeng Powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis
title_fullStr Identifying absorbable bioactive constituents of Yupingfeng Powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis
title_full_unstemmed Identifying absorbable bioactive constituents of Yupingfeng Powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis
title_short Identifying absorbable bioactive constituents of Yupingfeng Powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis
title_sort identifying absorbable bioactive constituents of yupingfeng powder acting on covid-19 through integration of uplc-q/tof-ms and network pharmacology analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828289/
https://www.ncbi.nlm.nih.gov/pubmed/35165529
http://dx.doi.org/10.1016/j.chmed.2022.02.001
work_keys_str_mv AT wanglinyan identifyingabsorbablebioactiveconstituentsofyupingfengpowderactingoncovid19throughintegrationofuplcqtofmsandnetworkpharmacologyanalysis
AT duzhongyan identifyingabsorbablebioactiveconstituentsofyupingfengpowderactingoncovid19throughintegrationofuplcqtofmsandnetworkpharmacologyanalysis
AT guanyang identifyingabsorbablebioactiveconstituentsofyupingfengpowderactingoncovid19throughintegrationofuplcqtofmsandnetworkpharmacologyanalysis
AT wangbo identifyingabsorbablebioactiveconstituentsofyupingfengpowderactingoncovid19throughintegrationofuplcqtofmsandnetworkpharmacologyanalysis
AT peiyanling identifyingabsorbablebioactiveconstituentsofyupingfengpowderactingoncovid19throughintegrationofuplcqtofmsandnetworkpharmacologyanalysis
AT zhanglizong identifyingabsorbablebioactiveconstituentsofyupingfengpowderactingoncovid19throughintegrationofuplcqtofmsandnetworkpharmacologyanalysis
AT fangmingsun identifyingabsorbablebioactiveconstituentsofyupingfengpowderactingoncovid19throughintegrationofuplcqtofmsandnetworkpharmacologyanalysis